Invest in ME Conference 12: First Class in Every Way
OverTheHills wraps up our series of articles on this year's 12th Invest in ME International Conference (IIMEC12) in London with some reflections on her experience as a patient attending the conference for the first time.
Discuss the article on the Forums.

(US) Contact Your Federal Legislator and Make Your Voice Heard about Specialty Tiers!

Discussion in 'Action Alerts and Advocacy' started by *GG*, Apr 18, 2012.

  1. *GG*

    *GG* senior member

    Concord, NH
    Advocacy Call to Action:
    A number of health insurance companies throughout

    the country are adopting a new specialty tier pricing system for expensive drugs, requiring patients to pay much more for life-saving and disease-stabilizing medications. Insurers are abandoning the traditional arrangement where patients pay a fixed co-pay amount and instead charging patients a percentage of the cost of certain high-priced drugs, usually 25 to 33 percent, which can amount to thousands of dollars a month for vital medications.

    The Patients' Access to Treatments Act of 2012 (H.R. 4209) was introduced in March by US House of Representatives David McKinley (R-WV) and Lois Capps (D-CA) to address this important issue. H.R. 4209 requires health insurers to place specialty drugs within the same classification as Tier III non-preferred drugs. It would allow people living with serious devastating health conditions to continue to have access to the critical treatments which they need in order to live active and productive lives.

    Click here to find your House Representative

    Read the complete article and available template letter.

See more popular forum discussions.

Share This Page